Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the first commercial eMTBR-Tau immunoassay, now ...
MTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer's disease Immunoassay for ...
SCCT2026 brings together clinicians and researchers from around the world to advance the science and practice of ...
And now, the thing that’s making all publishers wring their hands is AI – publishers are seeing massive drops to their web ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results